Abstract
Summary
Amoxicillin clavulanate potassium is suitable for lower respiratory tract infections, otitis media, sinusitis caused by β-lactamase producing Haemophilus influenzae and Moraxella catarrhalis; β-lactamase producing Staphylococcus aureus and enzyme producing intestines Bacteria such as Escherichia coli and Klebsiella caused urinary tract and skin and soft tissue infections; it can also be used for mild to moderate infections caused by enterococci. This product can also be used for the above-mentioned various infections caused by the non-enzyme-producing strains of the above-mentioned bacteria. This product is white or off-white suspended particles, fragrant and sweet. This product is a compound preparation, and its components are amoxicillin and potassium clavulanate.
LPI (LP Information)' newest research report, the “Amoxicillin and Clavulanate Potassium Industry Forecast” looks at past sales and reviews total world Amoxicillin and Clavulanate Potassium sales in 2022, providing a comprehensive analysis by region and market sector of projected Amoxicillin and Clavulanate Potassium sales for 2023 through 2029. With Amoxicillin and Clavulanate Potassium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amoxicillin and Clavulanate Potassium industry.
This Insight Report provides a comprehensive analysis of the global Amoxicillin and Clavulanate Potassium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amoxicillin and Clavulanate Potassium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amoxicillin and Clavulanate Potassium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amoxicillin and Clavulanate Potassium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amoxicillin and Clavulanate Potassium.
The global Amoxicillin and Clavulanate Potassium market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amoxicillin and Clavulanate Potassium players cover GSK, Pfizer, Sandoz, Health Biotech, Guangzhou Baiyunshan Pharmaceutical, Lunan Pharmaceutical Group, China National Pharmaceutical Group Corp, North China Pharmaceutical Group and Bright Future Pharmaceutical Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amoxicillin and Clavulanate Potassium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet
Oral Liquid
Segmentation by application
Hospital
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Pfizer
Sandoz
Health Biotech
Guangzhou Baiyunshan Pharmaceutical
Lunan Pharmaceutical Group
China National Pharmaceutical Group Corp
North China Pharmaceutical Group
Bright Future Pharmaceutical Laboratories
United Laboratories Internat
Simcere Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Amoxicillin and Clavulanate Potassium market?
What factors are driving Amoxicillin and Clavulanate Potassium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amoxicillin and Clavulanate Potassium market opportunities vary by end market size?
How does Amoxicillin and Clavulanate Potassium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Amoxicillin and Clavulanate Potassium Industry Forecast” looks at past sales and reviews total world Amoxicillin and Clavulanate Potassium sales in 2022, providing a comprehensive analysis by region and market sector of projected Amoxicillin and Clavulanate Potassium sales for 2023 through 2029. With Amoxicillin and Clavulanate Potassium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amoxicillin and Clavulanate Potassium industry.
This Insight Report provides a comprehensive analysis of the global Amoxicillin and Clavulanate Potassium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amoxicillin and Clavulanate Potassium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amoxicillin and Clavulanate Potassium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amoxicillin and Clavulanate Potassium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amoxicillin and Clavulanate Potassium.
The global Amoxicillin and Clavulanate Potassium market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amoxicillin and Clavulanate Potassium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amoxicillin and Clavulanate Potassium players cover GSK, Pfizer, Sandoz, Health Biotech, Guangzhou Baiyunshan Pharmaceutical, Lunan Pharmaceutical Group, China National Pharmaceutical Group Corp, North China Pharmaceutical Group and Bright Future Pharmaceutical Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amoxicillin and Clavulanate Potassium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet
Oral Liquid
Segmentation by application
Hospital
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Pfizer
Sandoz
Health Biotech
Guangzhou Baiyunshan Pharmaceutical
Lunan Pharmaceutical Group
China National Pharmaceutical Group Corp
North China Pharmaceutical Group
Bright Future Pharmaceutical Laboratories
United Laboratories Internat
Simcere Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Amoxicillin and Clavulanate Potassium market?
What factors are driving Amoxicillin and Clavulanate Potassium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amoxicillin and Clavulanate Potassium market opportunities vary by end market size?
How does Amoxicillin and Clavulanate Potassium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amoxicillin and Clavulanate Potassium Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amoxicillin and Clavulanate Potassium by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amoxicillin and Clavulanate Potassium by Country/Region, 2018, 2022 & 2029
2.2 Amoxicillin and Clavulanate Potassium Segment by Type
2.2.1 Tablet
2.2.2 Oral Liquid
2.3 Amoxicillin and Clavulanate Potassium Sales by Type
2.3.1 Global Amoxicillin and Clavulanate Potassium Sales Market Share by Type (2018-2023)
2.3.2 Global Amoxicillin and Clavulanate Potassium Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amoxicillin and Clavulanate Potassium Sale Price by Type (2018-2023)
2.4 Amoxicillin and Clavulanate Potassium Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amoxicillin and Clavulanate Potassium Sales by Application
2.5.1 Global Amoxicillin and Clavulanate Potassium Sale Market Share by Application (2018-2023)
2.5.2 Global Amoxicillin and Clavulanate Potassium Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amoxicillin and Clavulanate Potassium Sale Price by Application (2018-2023)
3 Global Amoxicillin and Clavulanate Potassium by Company
3.1 Global Amoxicillin and Clavulanate Potassium Breakdown Data by Company
3.1.1 Global Amoxicillin and Clavulanate Potassium Annual Sales by Company (2018-2023)
3.1.2 Global Amoxicillin and Clavulanate Potassium Sales Market Share by Company (2018-2023)
3.2 Global Amoxicillin and Clavulanate Potassium Annual Revenue by Company (2018-2023)
3.2.1 Global Amoxicillin and Clavulanate Potassium Revenue by Company (2018-2023)
3.2.2 Global Amoxicillin and Clavulanate Potassium Revenue Market Share by Company (2018-2023)
3.3 Global Amoxicillin and Clavulanate Potassium Sale Price by Company
3.4 Key Manufacturers Amoxicillin and Clavulanate Potassium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amoxicillin and Clavulanate Potassium Product Location Distribution
3.4.2 Players Amoxicillin and Clavulanate Potassium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Amoxicillin and Clavulanate Potassium by Geographic Region
4.1 World Historic Amoxicillin and Clavulanate Potassium Market Size by Geographic Region (2018-2023)
4.1.1 Global Amoxicillin and Clavulanate Potassium Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amoxicillin and Clavulanate Potassium Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amoxicillin and Clavulanate Potassium Market Size by Country/Region (2018-2023)
4.2.1 Global Amoxicillin and Clavulanate Potassium Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amoxicillin and Clavulanate Potassium Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amoxicillin and Clavulanate Potassium Sales Growth
4.4 APAC Amoxicillin and Clavulanate Potassium Sales Growth
4.5 Europe Amoxicillin and Clavulanate Potassium Sales Growth
4.6 Middle East & Africa Amoxicillin and Clavulanate Potassium Sales Growth
5 Americas
5.1 Americas Amoxicillin and Clavulanate Potassium Sales by Country
5.1.1 Americas Amoxicillin and Clavulanate Potassium Sales by Country (2018-2023)
5.1.2 Americas Amoxicillin and Clavulanate Potassium Revenue by Country (2018-2023)
5.2 Americas Amoxicillin and Clavulanate Potassium Sales by Type
5.3 Americas Amoxicillin and Clavulanate Potassium Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amoxicillin and Clavulanate Potassium Sales by Region
6.1.1 APAC Amoxicillin and Clavulanate Potassium Sales by Region (2018-2023)
6.1.2 APAC Amoxicillin and Clavulanate Potassium Revenue by Region (2018-2023)
6.2 APAC Amoxicillin and Clavulanate Potassium Sales by Type
6.3 APAC Amoxicillin and Clavulanate Potassium Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Amoxicillin and Clavulanate Potassium by Country
7.1.1 Europe Amoxicillin and Clavulanate Potassium Sales by Country (2018-2023)
7.1.2 Europe Amoxicillin and Clavulanate Potassium Revenue by Country (2018-2023)
7.2 Europe Amoxicillin and Clavulanate Potassium Sales by Type
7.3 Europe Amoxicillin and Clavulanate Potassium Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amoxicillin and Clavulanate Potassium by Country
8.1.1 Middle East & Africa Amoxicillin and Clavulanate Potassium Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amoxicillin and Clavulanate Potassium Revenue by Country (2018-2023)
8.2 Middle East & Africa Amoxicillin and Clavulanate Potassium Sales by Type
8.3 Middle East & Africa Amoxicillin and Clavulanate Potassium Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amoxicillin and Clavulanate Potassium
10.3 Manufacturing Process Analysis of Amoxicillin and Clavulanate Potassium
10.4 Industry Chain Structure of Amoxicillin and Clavulanate Potassium
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amoxicillin and Clavulanate Potassium Distributors
11.3 Amoxicillin and Clavulanate Potassium Customer
12 World Forecast Review for Amoxicillin and Clavulanate Potassium by Geographic Region
12.1 Global Amoxicillin and Clavulanate Potassium Market Size Forecast by Region
12.1.1 Global Amoxicillin and Clavulanate Potassium Forecast by Region (2024-2029)
12.1.2 Global Amoxicillin and Clavulanate Potassium Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amoxicillin and Clavulanate Potassium Forecast by Type
12.7 Global Amoxicillin and Clavulanate Potassium Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.1.3 GSK Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.2.3 Pfizer Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.3.3 Sandoz Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Health Biotech
13.4.1 Health Biotech Company Information
13.4.2 Health Biotech Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.4.3 Health Biotech Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Health Biotech Main Business Overview
13.4.5 Health Biotech Latest Developments
13.5 Guangzhou Baiyunshan Pharmaceutical
13.5.1 Guangzhou Baiyunshan Pharmaceutical Company Information
13.5.2 Guangzhou Baiyunshan Pharmaceutical Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.5.3 Guangzhou Baiyunshan Pharmaceutical Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Guangzhou Baiyunshan Pharmaceutical Main Business Overview
13.5.5 Guangzhou Baiyunshan Pharmaceutical Latest Developments
13.6 Lunan Pharmaceutical Group
13.6.1 Lunan Pharmaceutical Group Company Information
13.6.2 Lunan Pharmaceutical Group Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.6.3 Lunan Pharmaceutical Group Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lunan Pharmaceutical Group Main Business Overview
13.6.5 Lunan Pharmaceutical Group Latest Developments
13.7 China National Pharmaceutical Group Corp
13.7.1 China National Pharmaceutical Group Corp Company Information
13.7.2 China National Pharmaceutical Group Corp Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.7.3 China National Pharmaceutical Group Corp Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Pharmaceutical Group Corp Main Business Overview
13.7.5 China National Pharmaceutical Group Corp Latest Developments
13.8 North China Pharmaceutical Group
13.8.1 North China Pharmaceutical Group Company Information
13.8.2 North China Pharmaceutical Group Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.8.3 North China Pharmaceutical Group Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 North China Pharmaceutical Group Main Business Overview
13.8.5 North China Pharmaceutical Group Latest Developments
13.9 Bright Future Pharmaceutical Laboratories
13.9.1 Bright Future Pharmaceutical Laboratories Company Information
13.9.2 Bright Future Pharmaceutical Laboratories Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.9.3 Bright Future Pharmaceutical Laboratories Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bright Future Pharmaceutical Laboratories Main Business Overview
13.9.5 Bright Future Pharmaceutical Laboratories Latest Developments
13.10 United Laboratories Internat
13.10.1 United Laboratories Internat Company Information
13.10.2 United Laboratories Internat Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.10.3 United Laboratories Internat Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 United Laboratories Internat Main Business Overview
13.10.5 United Laboratories Internat Latest Developments
13.11 Simcere Pharmaceutical
13.11.1 Simcere Pharmaceutical Company Information
13.11.2 Simcere Pharmaceutical Amoxicillin and Clavulanate Potassium Product Portfolios and Specifications
13.11.3 Simcere Pharmaceutical Amoxicillin and Clavulanate Potassium Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Simcere Pharmaceutical Main Business Overview
13.11.5 Simcere Pharmaceutical Latest Developments
14 Research Findings and Conclusion